Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(((E)-4-hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate

Catalog No. :
ACGBII295
CAS No. :
174063-91-3
Molecular Formula :
C15H20N5Na2O8P
Molecular Weight :
475.31

IUPAC Name:sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(((E)-4-hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate

Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(((E)-4-hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(((E)-4-hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate
IUPAC Namesodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(((E)-4-hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate
Molecular FormulaC15H20N5Na2O8P
Molecular Weight475.31
SMILESO[C@H]1[C@H](N2C3=NC=NC(NC/C=C(CO)\C)=C3N=C2)O[C@H](COP([O-])([O-])=O)[C@H]1O.[Na+].[Na+]
InChI KeyWESACHJAWGKWJI-JPNCWPDTSA-L
Synonymtrans-Zeatin Riboside-5‘-monophosphate Disodium Salt (tZRMP);ribosyl zeatin 5'-phosphate
CAS No.174063-91-3

Synthetic Route by SureRoute

1. ACGBII295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGBII295 route product structure diagram
    ACGBII295174063-91-3
Inquiry

2. ACGBII295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGBII295 route product structure diagram
    ACGBII295174063-91-3
Inquiry

Comments (0)